Nearly one third of patients with advanced melanoma saw tumours disappear completely after receiving TIL therapy plus pembrolizumab immunotherapy
Results from a clinical trial have revealed nearly one third (29.2 per cent) of patients with advanced melanoma saw their tumours disappear completely on scans after receiving lifileucel TIL therapy […]
The ICR and The Royal Marsden partner with Mint Medical on roll out of global AI cancer imaging tool
The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech company Mint Medical, a Snke Company, to improve monitoring […]
Fundamentals of Bladder Cancer for Nurses and AHPs
VENUE: The Royal Marsden Education and Conference Centre, Chelsea, Stewart’s Grove, London SW3 6JJ It is with pleasure that we invite you to participate in this very exciting meeting. Start: 08:30, 30 […]
Introducing the Science Behind Targeted Treatments and Immunotherapies for Non-Small Cell Lung Cancer (NSCLC)
VENUE: The Royal Marsden Education and Conference Centre, London SW3 6JJ Dr Elaine Vickers, guides you through many of the most relevant topics relating to modern systemic treatments for non-small cell lung […]
Royal Marsden research shows benefits of early palliative care for patients with cancer
Research carried out at The Royal Marsden has found that early palliative care supports patients to live as well as possible throughout their cancer journey. The study, published in the […]
The Royal Marsden and Francis Crick Institute launches UK-wide programme into cancer immunotherapy response
A new programme has been launched, led by The Royal Marsden and the Francis Crick Institute, to better understand immunotherapy response and side effects in cancer. Funded through a £9 […]
State-of-the-art blood test to benefit lung cancer patients in expanded NHS study
A new ‘liquid biopsy test’ called the Marsden360 – developed by The Royal Marsden and Guardant Health – has already enabled over 2,000 patients with suspected advanced lung cancer to have […]
New AI collaboration could advance precision therapy in breast cancer
A new collaboration between academic and industry researchers could help to improve clinical decision making for cancer patients – including by potentially guiding the use of immunotherapy to breast cancer […]
Higher doses of radiotherapy cut treatment time by 75 per cent
Research led by The Royal Marsden has revealed that advanced radiotherapy technology can safely deliver curative treatment for prostate cancer patients in as few as five sessions, with only minimal side […]
Trial results support ‘new gold standard’ for head and neck cancer radiotherapy
Phase III trial results on a precision radiotherapy technique support a ‘new gold standard’ for treating head and neck cancer patients. The research suggests the new approach can reduce the […]
